Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates Mitofusin

Tekijä Ziviani, Elena, Tao, Ran N., Whitworth, Alexander J.
Julkaistu 2010

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

Tekijä Tain, Luke S, Mortiboys, Heather, Tao, Ran N, Ziviani, Elena, Bandmann, Oliver, Whitworth, Alexander J
Julkaistu 2009

A Nanobody Activation Immunotherapeutic That Selectively Destroys HER2-Positive Breast Cancer Cells

Tekijä Gray, Melissa A., Tao, Ran N., DePorter, Sandra M., Spiegel, David A., McNaughton, Brian R.
Julkaisussa Chembiochem (2015)

Exploring binding and effector functions of natural human antibodies using synthetic immunomodulators

Tekijä Jakobsche, Charles E., Parker, Christopher G., Tao, Ran N., Kolesnikova, Mariya D., Douglass, Eugene F., Spiegel, David A.
Julkaistu 2013

Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin

Tekijä Tain, Luke S., Chowdhury, Ruhena B., Tao, Ran N., Plun-Favreau, Helene, Moisoi, Nicoleta, Martins, L. Miguel, Downward, Julian, Whitworth, Alexander J., Tapon, Nicolas
Julkaistu 2009

Illuminating HIV gp120–Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules

Tekijä Parker, Christopher G., Dahlgren, Markus K., Tao, Ran N., Li, Don T., Douglass, Eugene F., Shoda, Takuji, Jawanda, Navneet, Spasov, Krasimir A., Lee, Sangil, Zhou, Nannan, Domaoal, Robert A., Sutton, Richard E., Anderson, Karen S., Jorgensen, William L., Krystal, Mark, Spiegel, David A.
Julkaistu 2014

Welwitindolinone C synthetic studies. Construction of the welwitindolinone carbon skeleton via a transannular nitrone cycloaddition

Tekijä Freeman, David B., Holubec, Alexandra A., Weiss, Matthew W., Dixon, Julie A., Kakefuda, Akio, Ohtsuka, Masami, Inoue, Munenori, Vaswani, Rishi G., Ohki, Hidenori, Doan, Brian D., Reisman, Sarah E., Stoltz, Brian M., Day, Joshua J., Tao, Ran N., Dieterich, Noah A., Wood, John L.
Julkaistu 2010